Eisai Inc. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings ...
Internal records reveal that for years Penn State’s clinical cancer research was mired in deep-rooted and potentially ...
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...
The global syndrome therapeutics market size was valued at US$ 147.4 Mn in 2024 and is projected to reach US$ 407.3 Mn by ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
The leading Familial Chylomicronemia Syndrome Companies such as Ionis Pharmaceuticals, Pfizer, Arrowhead Pharmaceuticals, ...
Sino Biopharmaceutical ( ($HK:1177) ) has shared an update. Sino Biopharmaceutical Limited announced that its innovative drug, LM-350 ‘CDH17 ADC’, ...
Clinical success achieved with one or two doses of TARA-002 in 88% of patientsTARA-002 demonstrated favorable safety and ...
Orforglipron is a small‑molecule, nonpeptide GLP‑1 receptor agonist taken once daily, and it skips some of the hassles that ...
News-Medical.Net on MSN
Red meat raises inflammation marker CRP in clinical trials
The review analyzes red meat's effects on inflammatory biomarkers, revealing significant associations with CRP in specific adult subgroups and dietary contexts.
The Global Electronic Data Capture Software Market Size projected to grow at a CAGR of 14.5% from 2024 to 2031, according to ...
Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback